To determine whether the ZEB2/TWIST1/PRMT5/NuRD complex can epigenetically regulate E-cadherin transcription in CRC, we further examined the levels of histone modifications, including H4R3me2 and H3K56ac, on the E-cadherin promoter by ChIP assay. This evidence concerns the gene ZEB2 and colorectal carcinoma.